期刊文献+

早孕期血清游离人绒毛膜促性腺激素、妊娠相关血浆蛋白A检测预测21-三体综合征的临床意义 被引量:3

Clinical significance of serum free human chorionic gonadotropin and pregnancy-associated plasma protein A in early pregnancy prediction of trisomy 21 syndrome
原文传递
导出
摘要 目的观察早孕期唐氏筛查中21-三体综合征(DS)不同风险产妇的血清游离人绒毛膜促性腺激素(Free-β-HCG)、妊娠相关血浆蛋白A(PAPPA)水平,分析Free-β-HcG、PAPPA水平预测DS高风险的价值。方法回顾性分析2018年1月-2019年12月本院早孕期唐氏筛查检出的DS高风险产妇的临床资料,从中筛选出符合条件的208例作为研究对象,DS组无DS组,另选同期早孕期唐氏筛查结果正常的产妇作为对照组。对比3组产妇的血清Free-β-HCG、PAPPA水平,采用双变量Pearson直线相关性分析检验DS高风险产妇血清Free-β-HCG、PAPPA水平间的关系。结果DS组产妇的Free-β-HCG水平最高、PAPPA水平最低,无DS组次之,对照组的Free-β-HCG水平最低、PAPPA水平最高,3组间差异有统计学意义(P<0.05);双变量Pearson直线相关性分析显示,DS高风险产妇的血清Free-β-HCG水平与PAPPA水平呈负相关(r=-0.855,P<0.05);血清Free-β-HCG、PAPPA水平预测DS发生的曲线下面积(AUC)分别为0.775、0.796,均>0.75,有一定预测价值。结论早孕期唐氏筛查检出的DS高风险产妇,若其血清Free-β-HCG过表达或(和)PAPPA水平低表达,可能预示DS风险极高,临床应重视这类产妇进一步DS筛查的严密性、严谨性及准确性,以减少漏诊发生。 Objective To observe the levels of free human chorionic gonadotropin(Free-β-HCG)and pregnancy-associated plasma protein A(PAPPA)in pregnant women with different risk ratio of first-trimester Down syndrome(DS)screening,and to analyze the value of Free-β-HCG and PAPPA levels in predicting the high risk of DS.Methods The clinical data of pregnant women with high-risk DS in first-trimester DS screening in the hospital from January 2018 to December 2019 were retrospectively analyzed.208 eligible cases were selected as DS group and non-DS group,and the pregnant women with normal results of first-trimester DS screening during the same period were selected as control group.The serum Free-β-HCG and PAPPA levels of the three groups were compared,and the relationship between serum Free-β-HCG and PAPPA levels of highrisk DS pregnant women was tested by bivariate Pearson linear correlation analysis.The receiver operating characteristic curve(ROC)was drawn to test the predictive value of serum Free-β-HCG and PAPPA levels in predicting DS.Results The level of Free-β-HCG in DS group was the highest,and the level of PAPPA was the lowest,followed by DS-free group,and the level of Free-β-HCG in control group was the lowest,and the level of PAPPA was the highest,and the differences among the three groups were statistically significant(P<0.05);Bivariate Pearson linear correlation analysis showed that serum Free-β-HCG levels of high-risk DS pregnant women were negatively correlated with PAPPA levels(r=-0.855,P<0.05);the area under the curve(AUC)of serum Free-β-HCG and PAPPA levels in predicting the occurrence of DS was 0.775 and0.796,respectively,both of which were greater than 0.75,which had certain predictive value.Conclusion For high-risk DS pregnant women in first-trimester DS screening,over-expression of serum Free-β-HCG or-(and)low expression of PAPPA may indicate the very high risk of DS.Clinical attention should be paid to the rigor,preciseness,and accuracy of further DS screening for such pregnant women,so as to reduce the incidence of missed diagnosis.
作者 陈卫青 CHEN Wei-qing(Taizhou Women and Children’s Hospital,Taizhou,Zhejiang 318000,China)
出处 《中国卫生检验杂志》 CAS 2021年第11期1347-1350,共4页 Chinese Journal of Health Laboratory Technology
关键词 21-三体综合征 游离人绒毛膜促性腺激素 妊娠相关血浆蛋白A 风险预测 Down syndrome Free human chorionic gonadotropin Pregnancy-associated plasma protein A Risk prediction
  • 相关文献

参考文献10

二级参考文献85

  • 1康媛,马端,李笑天.唐氏综合征的产前筛查[J].中国产前诊断杂志(电子版),2008(1):40-43. 被引量:2
  • 2聂良华,沈其君.产前筛查试验中MOM方法的原理及其应用[J].中国医院统计,2006,13(4):302-304. 被引量:14
  • 3Wald N J, Rodeck C, Hackshaw AK, et al. First and second trimes- ter antenatal Screening for Down's syndrome: the results of the Ser- um, Urine and Ultrasound Screening Study (SURUSS) [ J ]. J Med Screen, 2003, 10(2) :56-87.
  • 4Boaz W, Charles HR. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnan- cies [J]. Human Reproduction Update, 2006, 12(5) :513 -518.
  • 5Palacio M, Jaunianx E, Kingdom J, et al. Perinatal outcome in pregnancies with a positive serum sereening for Down's syndrome due to elevated levels of free beta - human ehorionic gonadotropin [ J ]. Ultrasound Obstet Gyneeol, 1999,13 ( 1 ) :58 "- 62.
  • 6中华人民共和国卫生部. WS322 胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准. 第1部分:中孕期母血清产前筛查[S]. 北京:中国标准出版社,2010.
  • 7NIX B,WRIGHT D,BAKER A. The impact ofbias in MoM values on patient risk and screeningperformance for Down syndrome[J]. Prenat Diagn,2007,27(9):840-845.
  • 8WALD NJ,KENNARD A,HACKSHAW A,et al.Antenatal screening for Down's syndrome [J]. HealthTechnol Assess,1988,2(1):i-iv.
  • 9田玉姣,岳天孚.唐氏综合征的产前诊断分子技术研究进展[J].国际妇产科学杂志,2008,35(1):12-15. 被引量:8
  • 10边旭明,刘俊涛,戚庆炜,蒋宇林,李岩,刘善英,郝娜,周京,吕时铭,朱宝生,王和,许争锋,潘小英,廖灿,蔡艳,王华,王泽,朱军,胡娅莉.对孕中期妇女行血清学二联指标筛查胎儿唐氏综合征的多中心前瞻性研究[J].中华妇产科杂志,2008,43(11):805-809. 被引量:63

共引文献98

同被引文献31

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部